Last year, the first phase 3 trial of Sage Therapeutics and Biogen's antidepressant hopeful zuranolone hit its efficacy targets, but raised doubts about the durability of the response. Now ...

Sage Therapeutics has left its view of Biogen's recent takeover bid in little doubt – it has just filed a lawsuit seeking to block the deal. Specific details of the lawsuit are not yet available ...

On the other hand, Verve Therapeutics VERV skyrocketed on positive data from a cholesterol study. Shares of Bristol Myers Squibb declined after the company announced that the late-stage ODYSSEY ...

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the ...

Assess today's live Priority Income Fund Inc Pref Series D (PRIF_pd) share price, performance and insights using our live NYSE: PRIF_pd stock exchange data. Analyse the historical data and Priority ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...